0|10000|Public
40|$|This review {{highlights}} the several advantages of buccal <b>drug</b> <b>delivery</b> system (BDDS) over the conventional and systemic formulation majorly. It helps to enhance bioavailability through bypassing {{the first pass}} metabolism. On this <b>drug</b> <b>delivery</b> system the formulation keeps {{in contact with the}} mucosal surface resulting in better absorption and prolonged resident time. Though all drugs are not suitable for this <b>drug</b> <b>delivery</b> system yet is useful for most of the drugs. Bioadhesive polymers roles a major part in this <b>drug</b> <b>delivery</b> system because the extent of Mucoadhesion is a very important phenomena for the buccal <b>drug</b> <b>delivery</b> system. This review covers merits and demerits of buccal <b>drug</b> <b>delivery</b> system, anatomy of oral mucosa, mechanism of drug permeation, polymers and permeation enhancer used in buccal <b>drug</b> <b>delivery</b> system. This review also covers available marketed product as buccal <b>drug</b> <b>delivery</b> system and future aspects of buccal <b>drug</b> <b>delivery</b> system...|$|R
40|$|Oral {{route of}} drug {{administration}} is considered as the safest and easiest route of drug administration. Control release <b>drug</b> <b>delivery</b> {{system is the}} emerging trend in the pharmaceuticals and the oral route is most suitable for such kind of <b>drug</b> <b>delivery</b> system. Oral route is more convenient for It all age group including both pediatric and geriatrics. There are various systems which are adopted to deliver drug {{in a controlled manner}} to different target sites through oral route. It includes diffusion controlled <b>drug</b> <b>delivery</b> systems; dissolution controlled <b>drug</b> <b>delivery</b> systems, osmotically controlled <b>drug</b> <b>delivery</b> systems, ion-exchange controlled <b>drug</b> <b>delivery</b> systems, hydrodynamically balanced systems, multi-Particulate <b>drug</b> <b>delivery</b> systems and microencapsulated <b>drug</b> <b>delivery</b> system. The systems are formulated using different natural, semi-synthetic and synthetic polymers. The purpose of the review is to provide information about the orally controlled <b>drug</b> <b>delivery</b> system, polymers which are used to formulate these systems and characterizations {{of one of the most}} convenient dosage form which is the tablets.   </p...|$|R
40|$|Sustained and {{controlled}} <b>drug</b> <b>delivery</b> system release the drug at a substantially steady {{rate of release}} per unit of time. However, there are instances where maintaining a constant blood level of a drug is not desirable. In such cases a pulsatile <b>drug</b> <b>delivery</b> may be more advantageous. Pulsatile <b>drug</b> <b>delivery</b> system (PDDS) is the most interesting time and site-specific system. This system is designed for chronopharmacotherapy {{which is based on}} circadian rhythm. Pulsatile <b>drug</b> <b>delivery</b> systems are gaining importance as these systems deliver the drug at specific time as per the pathophysiological need of the disease resulting in improved patient therapeutic efficacy and compliance. The current article focuses on the need for pulsatile <b>drug</b> <b>delivery</b> system, diseases requiring pulsatile <b>drug</b> <b>delivery</b> system, methodologies involved for the existing systems, application of natural polymers as drug release modifiers for pulsatile <b>drug</b> <b>delivery</b> systems with supportive studies on natural polymers as suitable candidates for pulsatile <b>drug</b> <b>delivery</b> systems and pulsatile <b>drug</b> <b>delivery</b> product currently available in the market...|$|R
40|$|This paper surveys {{methods for}} <b>drug</b> <b>delivery</b> and {{discusses}} micro-/nano-devices for controlled <b>drug</b> <b>delivery.</b> The {{concept of a}} micro-robot for controlled <b>drug</b> <b>delivery</b> and micro-needles for Chinese acupuncture are also presented. The proposed micro-needles can reduce pain and provide an alternative for <b>drug</b> <b>delivery</b> to the Chinese acupuncture treatment. Link_to_subscribed_fulltex...|$|R
40|$|This review {{explains}} the {{recent advances in}} gastroretentive <b>drug</b> <b>delivery</b> systems with special focus on floating <b>drug</b> <b>delivery</b> systems. Oral route is the most convenient and painless technique of <b>drug</b> <b>delivery.</b> Gastroretentive <b>drug</b> <b>delivery</b> systems have been developed which overcome physiological conditions in gastrointestinal tract such as short gastric resident time (GRT) and unpredictable gastric emptying times (GET). Various approaches used for prolonging GRT are mucoadhesive systems (Bioadhesive Systems), High Density Systems, Expandable Systems (Swelling Systems), Floating <b>Drug</b> <b>Delivery</b> systems (FDDS). In this review, authors discuss the current and recent research on gastroretentive <b>drug</b> <b>delivery</b> systems, including patented delivery systems and marketed products...|$|R
40|$|Abstract. An {{investigation}} on the melt <b>delivery</b> <b>tube</b> tip {{pressure and the}} effective atomizing efficiency of atomizing powder was carried out. The results show that all of melt <b>delivery</b> <b>tube</b> tip pressures are negative value in the atomization gas pressure range of 0. 4 ~ 0. 9 MPa, and they monotonously increase with increasing the atomizing pressure; when the atomizing pressure is higher than 0. 7 MPa, the negative pressure of the melt <b>delivery</b> <b>tube</b> tip is slowly increasing with continuously increasing the atomizing pressure; the atomized powder possesses higher effective atomizing efficiency, more uniform size distribution, better sphericity and smoother surface at the atomizing pressure of 0. 7 MPa and {{the pressure of the}} melt <b>delivery</b> <b>tube</b> tip of- 39. 44 kPa...|$|R
40|$|Magnetic micro and nano {{particles}} {{have been}} used for number of applications in various areas of biosciences, targeted <b>drug</b> <b>delivery</b> and in separation technology. Present discussion deals with applicability of magnetic particles as <b>drug</b> <b>delivery</b> system. The review includes mechanism of targeted <b>drug</b> <b>delivery</b> by magnetism, magnetic carriers, advantages, applications and past deign strategies of magnetic <b>drug</b> <b>delivery</b> system...|$|R
40|$|The {{success of}} local <b>drug</b> <b>delivery</b> and {{activation}} depends on several factors: • {{the degree of}} systemic distribution • localization of the <b>drug</b> <b>delivery</b> • permeation of the drug into the target tissue • timing of the local <b>drug</b> <b>delivery</b> or activation. C. T. W. Moonen 1 MR temperature mapping in local <b>drug</b> <b>delivery</b> and thermotherapy...|$|R
5000|$|Magnetic nanoparticle-based <b>drug</b> <b>delivery</b> {{is a means}} {{developed}} {{over the past several}} decades in which magnetic particles such as iron oxide nanoparticles have been a common component to design a <b>drug</b> <b>delivery</b> vehicle for magnetic <b>drug</b> <b>delivery,</b> due to their easiness and simplicity with a magnet-guidance. Magnetic nanoparticles impart imaging and controlled release capabilities to <b>drug</b> <b>delivery</b> materials, like micelles, liposomes, and polymers.|$|R
40|$|Today about 74 % {{of drugs}} are taken orally and are found {{not to be}} as {{effective}} as desired. To improve such characters transdermal <b>drug</b> <b>delivery</b> system was emerged. <b>Drug</b> <b>delivery</b> through the skin to achieve a systemic effect of a drug is commonly known as transdermal <b>drug</b> <b>delivery</b> and differs from traditional topical <b>drug</b> <b>delivery.</b> Transdermal <b>drug</b> <b>delivery</b> systems (TDDS) are dosage forms involves drug transport to viable epidermal and or dermal tissues of the skin for local therapeutic effect while a very major fraction of drug is transported into the systemic blood circulation. The adhesive of the transdermal <b>drug</b> <b>delivery</b> system is critical to the safety, efficacy and quality of the product. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive methods of <b>drug</b> <b>delivery.</b> Several important advantages of transdermal <b>drug</b> <b>delivery</b> are limitation of hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug...|$|R
40|$|Systems {{and methods}} are {{provided}} for a <b>drug</b> <b>delivery</b> device {{and use of}} the device for <b>drug</b> <b>delivery.</b> In various aspects, the <b>drug</b> <b>delivery</b> device combines a “solid drug in reservoir” (SDR) system with an electrolytic pump. In various aspects an improved electrolytic pump is provided including, in particular, an improved electrolytic pump for use with a <b>drug</b> <b>delivery</b> device, for example an implantable <b>drug</b> <b>delivery</b> device. A catalytic reformer can be incorporated in a periodically pulsed electrolytic pump to provide stable pumping performance and reduced actuation cycle...|$|R
40|$|In recent years, glucose-sensitive <b>drug</b> <b>delivery</b> {{systems have}} {{attracted}} considerable {{attention in the}} treatment of diabetes. These systems can regulate payload release by the changes of blood glucose levels continuously and automatically with potential application in self-regulated <b>drug</b> <b>delivery.</b> Boronic acid (BA), especially phenylboronic acid (PBA), as glucose-sensitive agent {{has been the focus of}} research in the design of glucose-sensitive platforms. This article reviews the previous attempts at the developments of PBA-based glucose-sensitive <b>drug</b> <b>delivery</b> systems regarding the PBA-functionalized materials and glucose-triggered <b>drug</b> <b>delivery.</b> The obstacles and potential developments of glucose-sensitive <b>drug</b> <b>delivery</b> systems based on PBA for diabetes treatment in the future are also described. The PBA-functionalized platforms that regulate <b>drug</b> <b>delivery</b> induced by glucose are expected to contribute significantly to the design and development of advanced intelligent self-regulated <b>drug</b> <b>delivery</b> systems for treatment of diabetes...|$|R
40|$|In this review, {{the various}} new and well {{established}} technologies {{relevant to the}} controlled and targeted <b>drug</b> <b>delivery</b> systems have been precisely discussed. A perfectly designed controlled <b>drug</b> <b>delivery</b> system can be of huge advantage towards solving problems concerning to the targeting of drug to a specific organ or tissue and controlling the rate of <b>drug</b> <b>delivery</b> at the target site. Novel <b>drug</b> <b>delivery</b> systems have various advantages over other conventional drug therapy. In which microencapsulation is one approach for achieving the novel <b>drug</b> <b>delivery</b> dosage forms such as sustained release and controlled release, though the development of oral controlled release systems has been a challenge to formulation scientist due to their inability to restrain and focus the system at targeted areas of gastrointestinal tract. Microparticulate <b>drug</b> <b>delivery</b> systems are an interesting and promising option when developing an oral controlled release system. Our objective {{is to take a}} closer look at microparticles as <b>drug</b> <b>delivery</b> devices for increasing efficiency of <b>drug</b> <b>delivery,</b> improving the release profile and drug targeting. In order to elucidate the application of microcapsules in <b>drug</b> <b>delivery,</b> some fundamental aspects are briefly reviewed...|$|R
5000|$|Particle-based <b>drug</b> <b>delivery</b> systems (e.g. liposomes, nano- and micro- bubbles, polymers, [...] "Smart" [...] <b>drug</b> <b>delivery</b> particles, etc) ...|$|R
40|$|AbstractFor many years, <b>drug</b> <b>delivery</b> to {{the inner}} ear has been a {{challenge}} to physicians {{in the treatment of}} inner ear disorders. In the past decade, the field of inner ear <b>drug</b> <b>delivery</b> has emerged with the development of new biomaterials and <b>drug</b> <b>delivery</b> technologies to improve the effectiveness of inner ear drug therapy. This paper reviews a number of inner ear <b>drug</b> <b>delivery</b> strategies including systemic, intratympanic, and intracochlear delivery. A focus of this review is the recent advances in intratympanic delivery of medications; approaches utilizing novel biomaterials as well as other recent developments are also discussed. Biotechnology-based approaches, such as gene and stem cell therapy methods are also reviewed. Among the various strategies, local <b>drug</b> <b>delivery</b> approaches including intratympanic and intracochlear <b>drug</b> <b>delivery</b> methods that limit systemic exposure are particularly promising. These inner ear <b>drug</b> <b>delivery</b> systems provide a new opportunity to improve the treatment of inner ear disorders...|$|R
40|$|ABSTRACT: Nasal <b>drug</b> <b>delivery</b> has {{occupied}} {{an important}} {{place in the}} field of <b>drug</b> <b>delivery</b> technology. Transmucosal nasal delivery is a promising <b>drug</b> <b>delivery</b> option where common drug administration’s (e. g. intravenous, intramuscular, and oral) are inapplicable. This route is also advisable for drugs undergoing extensive first pass effect. The physiology of the nose presents obstacles, but offers a promising route for non-invasive systemic delivery of numerous therapies and debatably <b>drug</b> <b>delivery</b> route to the brain. Nasal route is easily accessible for selfadministration without the help of health professionals and no needle stick hazards are associated with nasal administration. To overcome these problems in nasal <b>drug</b> <b>delivery,</b> deep understanding and study of the various factors affecting nasal delivery is muust. Thus present review focuses on various aspects of nasal <b>drug</b> <b>delivery</b> with special emphasis on various formulations available, obstacles, advancement and future prospects in nasal <b>drug</b> <b>delivery...</b>|$|R
40|$|For many years, <b>drug</b> <b>delivery</b> to {{the inner}} ear has been a {{challenge}} to physicians {{in the treatment of}} inner ear disorders. In the past decade, the field of inner ear <b>drug</b> <b>delivery</b> has emerged with the development of new biomaterials and <b>drug</b> <b>delivery</b> technologies to improve the effectiveness of inner ear drug therapy. This paper reviews a number of inner ear <b>drug</b> <b>delivery</b> strategies including systemic, intratympanic, and intracochlear delivery. A focus of this review is the recent advances in intratympanic delivery of medications; approaches utilizing novel biomaterials as well as other recent developments are also discussed. Biotechnology-based approaches, such as gene and stem cell therapy methods are also reviewed. Among the various strategies, local <b>drug</b> <b>delivery</b> approaches including intratympanic and intracochlear <b>drug</b> <b>delivery</b> methods that limit systemic exposure are particularly promising. These inner ear <b>drug</b> <b>delivery</b> systems provide a new opportunity to improve the treatment of inner ear disorders...|$|R
40|$|Trasdermal <b>drug</b> <b>delivery</b> {{system is}} topically {{administered}} medicaments {{in the form}} of patches that deliver drugs for systemic effects at a predetermined and controlled rate. Today about 74 % of drugs are taken orally and are found not to be as effective as desired. To improve such characters transdermal <b>drug</b> <b>delivery</b> system was emerged. <b>Drug</b> <b>delivery</b> through the skin to achieve a systemic effect of a drug is commonly known as transdermal <b>drug</b> <b>delivery</b> and differs from traditional topical <b>drug</b> <b>delivery.</b> This review article is written to provide a coverage commentary of the recent advancements in TDD enhancement techniques. Skin penetration enhancement techniques have been developed to improve bioavailability and increase the range of drugs for which topical and transdermal delivery is a viable option. The present review article explores the overall study on transdermal <b>drug</b> <b>delivery</b> system (TDDS) which leads to novel <b>drug</b> <b>delivery</b> system (NDDS) ...|$|R
50|$|However, {{recently}} novel nanoparticulate <b>drug</b> <b>delivery</b> {{systems such}} as AmbiOnp, nanosuspensions, lipid-based <b>drug</b> <b>delivery</b> systems including cochleates, self-emulsifying <b>drug</b> <b>delivery</b> systems, solid lipid nanoparticles and polymeric nanoparticles—such as Amphotericin B in pegylated polylactide coglycolide copolymer nanoparticles—have demonstrated potential for oral formulation of amphotericin B.|$|R
40|$|Oral <b>drug</b> <b>delivery</b> {{remains the}} {{preferred}} route of <b>drug</b> <b>delivery.</b> Novel technologies with improved performance, patient compliance, and enhanced quality {{have emerged in}} the recent past. The fast dissolving <b>drug</b> <b>delivery</b> system started gaining popularity and acceptance as a new <b>drug</b> <b>delivery</b> system because {{they are easy to}} administer and lead to better patient compliance. Fast dissolving <b>drug</b> <b>delivery</b> system can be obtained by the various techniques i. e. direct compression, tablet molding, freeze drying, spray drying nanonization. Oral fast-dissolving tablets, are an examples of a few existing technologies with the potential to accommodate various physicochemical, pharmacokinetic and pharmacodynamic characteristic of drugs...|$|R
40|$|Keywords:iontophoresis; <b>drug</b> <b>delivery</b> system; {{electrodes}} Abstract:This study {{presents the}} development of a <b>drug</b> <b>delivery</b> system using iontophoresis for alopecia treatment. A alopecia is a medical description which means loss of hair from the body. To treat this condition, the drugs for alopecia treatment need to be delivered into the scalp. Therefore, iontophoresis was used in a portable <b>drug</b> <b>delivery</b> system to enhance the penetration of the <b>drug</b> <b>delivery.</b> The designed system consisted of a drug container, iontophoresis circuit board and re-chargeable battery. According to the results, the iontophoresis circuit board performed well along with the designed <b>drug</b> <b>delivery</b> system...|$|R
40|$|Nanotechnology {{has finally}} and firmly entered {{the realm of}} <b>drug</b> <b>delivery.</b> Performances of {{intelligent}} <b>drug</b> <b>delivery</b> systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. This review describes the advanced <b>drug</b> <b>delivery</b> systems based on micelles, polymeric nanoparticles, and dendrimers. Polymeric carbon nanotubes and many others demonstrate a broad variety of useful properties. This review emphasizes the main requirements for developing new nanotech-nology-based <b>drug</b> <b>delivery</b> systems...|$|R
40|$|<b>Drug</b> <b>delivery</b> to tumours and the {{accessibility}} of tumour cells to drugs remains a problem of foremost importance and is affected by many factors. We will discuss models we have developed for <b>drug</b> <b>delivery</b> from tumour capillaries to tumour cells, and <b>drug</b> <b>delivery</b> from well perfused, well oxygenated tumour regions to less well perfused hypoxic regions in terms of computer simulation of <b>drug</b> <b>delivery</b> for the anticancer agent BCNU and the hypoxic cell radiosensitizer misonidazole...|$|R
30|$|In {{past few}} decades, {{scientists}} have made tremendous advancement {{in the field}} of <b>drug</b> <b>delivery</b> systems (DDS), through transdermal pathway, as the skin represents a ready and large surface area for delivering drugs. Efforts are in progress to design efficient transdermal DDS that support sustained drug release at the targeted area for longer duration in the recommended therapeutic window without producing side-effects. Poly(lactic-co-glycolic acid) (PLGA) {{is one of the most}} promising Food and Drug Administration approved synthetic polymers in designing versatile <b>drug</b> <b>delivery</b> carriers for different drug administration routes, including transdermal <b>drug</b> <b>delivery.</b> The present review provides a brief introduction over the transdermal <b>drug</b> <b>delivery</b> and PLGA as a material in context to its role in designing <b>drug</b> <b>delivery</b> vehicles. Attempts are made to compile literatures over PLGA-based <b>drug</b> <b>delivery</b> vehicles, including microneedles, nanoparticles, and nanofibers and their role in transdermal <b>drug</b> <b>delivery</b> of different therapeutic agents. Different nanostructure evaluation techniques with their working principles are briefly explained.|$|R
40|$|AbstractNumerous {{systems have}} been {{designed}} {{during the past three}} decades to improve bioavailability of ophthalmic <b>drug</b> <b>delivery,</b> including: ocular prodrugs and nanotechnology-based <b>drug</b> <b>delivery</b> system. The former can improve the efficacy of ocular drug via enhancing corneal penetration of ocular drugs, prolonging their duration of action and/or reducing the systemic side-effects, unfortunately, some characteristics of the prodrugs, such as poorly aqueous stability, poorly aqueous solubility and severe eye irritation probably, limit their clinical practice and cannot be ignored. As we all know, nanotechnology for ocular <b>drug</b> <b>delivery</b> can carry poorly soluble drugs, protect the encapsulated molecules from hydrolysis, control the rate of <b>drug</b> <b>delivery</b> and prolong the precorneal retention of drugs. All of these merits may solve the problems in the utilization of ocular prodrugs and increase the bioavailability of ocular <b>drug</b> <b>delivery.</b> By reviewing recent advances of prodrugs and nanostructures in ocular <b>drug</b> <b>delivery,</b> this paper focus specifically on the promising prospects of nanocarriers overcoming the drawbacks of prodrugs for ophthalmic <b>drug</b> <b>delivery</b> by precorneal routes...|$|R
50|$|Biopharmaceutical sciences: Research in the {{biopharmaceutical}} sciences involves pharmaceutics (<b>drug</b> <b>delivery),</b> pharmacodynamics (<b>drug</b> action), pharmacokinetics (absorption {{and distribution}} properties) and pharmacogenomics. Specific research programs include: Lipid and polymer-based <b>drug</b> <b>delivery</b> systems, targeted <b>drug</b> <b>delivery,</b> pharmacokinetic membrane transport and absorption, behavioral pharmacology, cardiovascular pharmacology, neuropharmacology, environmental toxicology, cancer chemotherapy.|$|R
40|$|Peptide self-assembled {{nanostructures}} {{are very}} popular in many biomedical applications. <b>Drug</b> <b>delivery</b> {{is one of the}} most promising applications among them. The tremendous advantages for peptide self-assembled nanostructures include good biocompatibility, low cost, tunable bioactivity, high drug loading capacities, chemical diversity, specific targeting, and stimuli responsive <b>drug</b> <b>delivery</b> at disease sites. Peptide self-assembled nanostructures such as nanoparticles, nanotubes, nanofibers, and hydrogels have been investigated by many researchers for <b>drug</b> <b>delivery</b> applications. In this review, the underlying mechanisms for the self-assembled nanostructures based on peptides with different types and structures are introduced and discussed. Peptide self-assembled nanostructures associated promising <b>drug</b> <b>delivery</b> applications such as anticancer drug and gene <b>drug</b> <b>delivery</b> are highlighted. Furthermore, peptide self-assembled nanostructures for targeted and stimuli responsive <b>drug</b> <b>delivery</b> applications are also reviewed and discussed...|$|R
40|$|Now a days, The novel <b>drug</b> <b>delivery</b> {{system is}} {{creating}} a new interest in development of <b>drug</b> <b>deliveries.</b> Vesicular <b>drug</b> <b>delivery</b> system in {{also a part of}} this novel <b>drug</b> <b>delivery</b> system which is designed according to the recent demands of treatment like sustain release of drug in systemic circulation, definite dosing interval. Transferosomes are part of this vesicular <b>drug</b> <b>delivery</b> system which are altered deformable vesicles used to enhance skin penetration. It is also a controlled & targeted <b>drug</b> <b>delivery</b> system which is used to increase the existence of drug in systemic circulation & decrease the toxicity. Transferosomes are proposed for variety of applications in humans like as carrier for insulin & vaccines. In this review, we mainly focus on transferosome with its applications, limitations, advantages & preparation...|$|R
40|$|Chitosan is a {{promising}} biopolymer for <b>drug</b> <b>delivery</b> systems. Because of its beneficial properties, chitosan {{is widely used}} in biomedical and pharmaceutical fields. In this review, we summarize the physicochemical and <b>drug</b> <b>delivery</b> properties of chitosan, selected studies on utilization of chitosan and chitosan-based nanoparticle composites in various <b>drug</b> <b>delivery</b> systems, and selected studies on the application of chitosan films in both <b>drug</b> <b>delivery</b> and wound healing. Chitosan is considered the most important polysaccharide for various <b>drug</b> <b>delivery</b> purposes because of its cationic character and primary amino groups, which are responsible for its many properties such as mucoadhesion, controlled drug release, transfection, in situ gelation, and efflux pump inhibitory properties and permeation enhancement. This review can enhance our understanding of <b>drug</b> <b>delivery</b> systems particularly in cases where chitosan drug-loaded nanoparticles are applied...|$|R
40|$|An {{appropriately}} designed {{controlled release}} <b>drug</b> <b>delivery</b> {{system can be}} a major advance towards solving problems concerning to the targeting of drug to a specific organ or tissue and controlling the rate of <b>drug</b> <b>delivery</b> to the target site. The development of oral controlled release systems has been a challenge to formulation scientist due to their inability to restrain and localize the system at targeted areas of gastrointestinal tract. Microparticulate <b>drug</b> <b>delivery</b> systems are an interesting and promising option when developing an oral controlled release system. The objective {{of this paper is}} to take a closer look at microparticles as <b>drug</b> <b>delivery</b> devices for increasing efficiency of <b>drug</b> <b>delivery,</b> improving the release profile and drug targeting. In order to appreciate the application possibilities of microcapsules in <b>drug</b> <b>delivery,</b> some fundamental aspects are briefly reviewed...|$|R
40|$|AbstractChitosan is a {{promising}} biopolymer for <b>drug</b> <b>delivery</b> systems. Because of its beneficial properties, chitosan {{is widely used}} in biomedical and pharmaceutical fields. In this review, we summarize the physicochemical and <b>drug</b> <b>delivery</b> properties of chitosan, selected studies on utilization of chitosan and chitosan-based nanoparticle composites in various <b>drug</b> <b>delivery</b> systems, and selected studies on the application of chitosan films in both <b>drug</b> <b>delivery</b> and wound healing. Chitosan is considered the most important polysaccharide for various <b>drug</b> <b>delivery</b> purposes because of its cationic character and primary amino groups, which are responsible for its many properties such as mucoadhesion, controlled drug release, transfection, in situ gelation, and efflux pump inhibitory properties and permeation enhancement. This review can enhance our understanding of <b>drug</b> <b>delivery</b> systems particularly in cases where chitosan drug-loaded nanoparticles are applied...|$|R
40|$|With the {{emergence}} of Nanotechnology, there has been remarkable improvement {{in the field of}} <b>drug</b> <b>delivery</b> system over the past decade. Nanotechnology in <b>drug</b> <b>delivery</b> system is an upcom-ing field and significant research has been conducted in this regard. It has been able to overcome some limitations encountered with the traditional routine <b>drug</b> <b>delivery</b> systems and hence emerged as an effective alternative. This article reviews nanotechnology based different types of <b>drug</b> <b>delivery</b> systems and their therapeutic applications...|$|R
40|$|Ultrasound-mediated <b>drug</b> <b>delivery</b> {{under the}} {{guidance}} of an imaging modality can improve drug disposition and achieve site-specific <b>drug</b> <b>delivery.</b> The term focal <b>drug</b> <b>delivery</b> has been introduced to describe the focal targeting of drugs in tissues with the help of imaging and focused ultrasound. Focal <b>drug</b> <b>delivery</b> aims to improve the therapeutic profile of drugs by improving their specificity and their permeation in defined areas. Focused-ultrasound- (FUS-) mediated <b>drug</b> <b>delivery</b> has been applied with various molecules to improve their local distribution in tissues. FUS is applied with the aid of microbubbles to enhance the permeability of bioactive molecules across BBB and improve drug distribution in the brain. Recently, FUS has been utilised in combination with MRI-labelled liposomes that respond to temperature increase. This strategy aims to “activate” nanoparticles to release their cargo locally when triggered by hyperthermia induced by FUS. MRI-guided FUS <b>drug</b> <b>delivery</b> provides the opportunity to improve drug bioavailability locally and therefore improve the therapeutic profiles of <b>drugs.</b> This <b>drug</b> <b>delivery</b> strategy can be directly translated to clinic as MRg FUS is a promising clinically therapeutic approach. However, more basic research is required to understand the physiological mechanism of FUS-enhanced <b>drug</b> <b>delivery...</b>|$|R
40|$|Drugs are {{administered}} by using different <b>drug</b> <b>delivery</b> systems. A number of <b>drug</b> <b>delivery</b> systems have {{evolved over the}} years. In the last 20 years TDDS (Transdermal <b>drug</b> <b>delivery</b> system) has been growing at a rapid pace. Now the micro needles are being developed as a novel <b>drug</b> <b>delivery</b> system. The micro needle skin patch system is also a <b>drug</b> <b>delivery</b> system, which will be used transdermally. The success of TDD has severely limited by the inability of most drugs to enter the skin at therapeutical useful rates. Thus, the use of micro-needle patches in increasing skin permeability has been proposed and shown to dramatically increase in transdermal delivery, especially for macromolecules. Using {{the tools of the}} microelectronics industry, microneedles have been fabricated with a range of sizes, shapes and materials. Most <b>drug</b> <b>delivery</b> studies have emphasized microneedles, which have been shown to increase the skin permeability to a broad range of molecules and nanoparticles invitro. This review briefly deals with types, mode of <b>drug</b> <b>delivery,</b> coating and applications of microneedle patches. Overall the microneedle skin patches are prone to be a very versatile <b>drug</b> <b>delivery</b> technology, allowing easy and reproducible delivery to skin...|$|R
40|$|Various new {{technologies}} {{have been developed}} for the transdermal delivery of some important drugs. Today about 74 % of drugs are taken orally and are found not to be as effective as desired. To improve such characters transdermal <b>drug</b> <b>delivery</b> system was emerged. <b>Drug</b> <b>delivery</b> through the skin to achieve a systemic effect of a drug is commonly known as transdermal <b>drug</b> <b>delivery</b> and differs from traditional topical <b>drug</b> <b>delivery.</b> Transdermal <b>drug</b> <b>delivery</b> systems (TDDS) are dosage forms involves drug transport to viable epidermal and or dermal tissues of the skin for local therapeutic effect while a very major fraction of drug is transported into the systemic blood circulation. The adhesive of the transdermal <b>drug</b> <b>delivery</b> system is critical to the safety, efficacy and quality of the product. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive methods of <b>drug</b> <b>delivery.</b> This review article provides an overview of TDDS, its advantages over conventional dosage forms, <b>drug</b> <b>delivery</b> routes across human skin, penetration enhancers, various components of Transdermal patches, types of Transdermal patches, methods of preparation and its physicochemical methods of evaluation...|$|R
40|$|There {{has been}} keen {{interest}} {{in the development of}} a novel <b>drug</b> <b>delivery</b> system. Novel <b>drug</b> <b>delivery</b> system aims to deliver the drug at a rate directed by the needs of the body during the period of treatment, and channel the active entity to the site of action. At present, no available <b>drug</b> <b>delivery</b> system behaves ideally achieving all the lofty goals, but sincere attempts have been made to achieve them through novel approaches in <b>drug</b> <b>delivery.</b> A number of novel <b>drug</b> <b>delivery</b> systems have emerged encompassing various routes of administration, to achieve controlled and targeted <b>drug</b> <b>delivery.</b> Encapsulation of the drug in vesicular structures is one such system, which can be predicted to prolong the existence of the drug in systemic circulation, and reduce the toxicity, if selective uptake can be achieved. Consequently a number of vesicular <b>drug</b> <b>delivery</b> systems such as liposomes, niosomes, transfersomes, and pharmacosomes were developed. Advances have since been made in the area of vesicular <b>drug</b> <b>delivery,</b> leading to the development of systems that allow drug targeting, and the sustained or controlled release of conventional medicines. The focus of this review is to bring out the application, advantages, and drawbacks of vesicular systems...|$|R
